Pandemic Timeline

Genyous Biomed files patent AU2011323155: Combination therapy for prostate cancer using botanical compositions and bicalutamide

Botanical compositions comprising non-alcoholic organic extracts of Ganoderma lucidum, Salvia miltiorrhiza, and Scutellaria barbata for use in conjunction with bicalutamide therapy fpr cancer therapy, are provided. Methods for treatment or therapy of prostate cancer in a human is provided, the method comprising: administering an effective amount of a botanical composition that is effective for reducing androgen receptor protein expression; and administering concurrently an effective amount of a compound having anti-androgen activity, wherein the concurrent administration of the compound and the botanical composition achieves a therapeutic effect that is more effective than either agent alone.

Patent AU2011323155B2

Sources:

  • Patent
    May 12, 2016. James Dao, Jeffrey Dao, Allen Chuan Gao, Lena Gerwick, William Gerwick, Maryann Jordan, Judy Mikovits, Tatiana Okouneva, and Emin Oroudjev. Combination therapy for prostate cancer using botanical compositions and bicalutamide. AU2011323155B2, filed November 4, 2011, and issued May 12, 2016. Assignee: GENYOUS BIOMED INTERNATIONAL
    https://patents.google.com/patent/AU2011323155B2,
    Local copy.
    Patent.
  • Video
    May 31, 2023. Clay Clark with Judy Mikovits. Dr. Mikovits | Vaccine Nanotechnology | Doctor Judy Mikovits Breaks Down the Nefarious Patents | Who Is Developing Vaccine Nanotechnology? What Does Vaccine Nanotechnology Mean? (Read the Patents In the Description). Thrivetime Show: The ReAwakening versus The Great Reset. Runtime: 55:34.
    https://rumble.com/v2r7wc0-dr.-mikovits-vaccine-nanotechnology-.html.
    Video.
  • Blog
    Karen Kingston. “Karen Kingston | Substack.
    https://substack.com/@karenkingston.
    Blog.

See also, on this site:

Comments are closed.